WHO Public Call: Update of the WHO high-priority target product profiles for TB diagnostics

In 2014, in an effort to inform and help steer research and development priorities for TB diagnostic tools, the World Health Organization released its high-priority target product profiles for new TB diagnostics.
As part of the revision process, WHO is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation DST. Comments can be submitted from 7 – 31 January 2021, 18:00 CET.
The online survey tool can be accessed here: Proposed Target Product Profile for Next-Generation Drug-Susceptibility Testing at Peripheral Centres